|
|
|
Insider
Information: |
Steinmetz Michael |
Relationship: |
Former 10% stockholder |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
37,029,187 |
|
Indirect Shares
|
18,165,939 |
|
|
Direct
Value |
$300,418,977 |
|
|
Indirect Value
|
$337,643,891 |
|
|
Total
Shares |
55,195,126 |
|
|
Total
Value |
$638,062,868 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Oscient Pharmaceuticals Corp |
OSCIQ |
10% Owner |
2004-02-06 |
7,597,351 |
2009-05-15 |
4,222 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-08-02 |
0 |
2004-08-02 |
1,833,597 |
Premium* |
|
Acorda Therapeutics Inc |
ACOR |
Director |
2006-02-15 |
0 |
2006-02-15 |
1,806,800 |
Premium* |
|
Avanir Pharmaceuticals |
AVNR |
10% Owner |
2008-04-04 |
15,557,318 |
2010-12-03 |
12 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2008-08-13 |
5,163,689 |
2012-06-04 |
3 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
5,982,439 |
2011-09-16 |
9,482,439 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2013-09-30 |
2,728,390 |
2013-09-30 |
0 |
Premium* |
|
Oxford Immunotec Global Plc |
OXFD |
Director, 10% Owner |
|
0 |
2013-11-21 |
2,579,062 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
2,459,804 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OSCIQ |
Oscient Pharmaceuticals C... |
10% Owner |
|
2004-02-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,597,351 |
|
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2008-04-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,557,318 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2008-08-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,163,689 |
|
- |
|
OXFD |
Oxford Immunotec Global P... |
Director |
|
2013-11-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,579,062 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2008-09-08 |
4 |
B |
$2.37 |
$3,791 |
I/I |
1,600 |
5,307,420 |
1.42 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-02 |
4 |
S |
$18.68 |
$36,762 |
I/I |
(1,968) |
1,833,597 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2008-09-05 |
4 |
B |
$2.19 |
$6,693 |
I/I |
3,054 |
5,305,820 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-24 |
4 |
AS |
$3.53 |
$12,695 |
I/I |
(3,600) |
4,673,567 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-01-07 |
4 |
AS |
$3.50 |
$12,600 |
I/I |
(3,600) |
4,620,567 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
10% Owner |
|
2009-05-15 |
4 |
OE |
$1.10 |
$4,644 |
I/I |
4,222 |
4,222 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-18 |
4 |
AS |
$3.50 |
$34,650 |
I/I |
(9,900) |
4,961,167 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-21 |
4 |
AS |
$3.54 |
$67,664 |
I/I |
(19,100) |
4,942,067 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-08 |
4 |
S |
$5.10 |
$227,593 |
I/I |
(44,626) |
7,869,216 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-01-06 |
4 |
AS |
$3.50 |
$173,033 |
I/I |
(49,400) |
4,624,167 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-16 |
4 |
AS |
$3.58 |
$242,507 |
I/I |
(67,800) |
5,100,543 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-17 |
4 |
AS |
$3.50 |
$453,166 |
I/I |
(129,476) |
4,971,067 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-07-13 |
4 |
S |
$3.53 |
$583,143 |
I/I |
(165,000) |
15,392,318 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2006-02-15 |
4 |
B |
$6.00 |
$1,000,002 |
I/I |
166,667 |
1,806,800 |
2.1 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-01-11 |
4 |
AS |
$3.77 |
$881,370 |
I/I |
(233,990) |
4,386,577 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-10-08 |
4 |
S |
$3.47 |
$836,792 |
I/I |
(240,838) |
15,151,480 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2009-12-23 |
4 |
AS |
$3.70 |
$981,428 |
I/I |
(264,900) |
4,677,167 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-10-11 |
4 |
S |
$3.52 |
$1,093,445 |
I/I |
(311,000) |
14,840,480 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-05 |
4 |
S |
$4.80 |
$1,597,377 |
I/I |
(332,572) |
7,913,842 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
10% Owner |
|
2010-11-09 |
4 |
S |
$4.81 |
$5,773,920 |
I/I |
(1,200,000) |
6,669,216 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Former 10% stockholder |
|
2016-09-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,229,902) |
2,459,804 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|